Home > Healthcare > Medical Devices > Diagnostic Devices > Tissue Diagnostics Market

Tissue Diagnostics Market Share

Report ID: GMI3754
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Tissue Diagnostics Market Share

Some of the notable key tissue diagnostics market players operating in the tissue diagnostics industry include

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens
Danaher
bioMérieux SA
QIAGEN
Becton Dickinson & Company
Merck KGaA
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc
GE Healthcare
BioGenex
Cell Signaling Technology, Inc.

Authors: Mariam Faizullabhoy , Subodh Kharad

Frequently Asked Questions (FAQ) :

Global tissue diagnostics industry size was over USD 5 billion in 2022 and will reach more than USD 11 billion by 2032.

The digital pathology technology segment will witness a 8.6% CAGR between 2023 to 2032 due to an in the adoption of whole-slide imaging (WSI) by pathologists.

U.S. tissue diagnostics market will be valued at more than USD 3 billion by 2032 as to high incidence rate of cancer.

F. Hoffmann-La Roche Ltd., Siemens, Danaher, bioMérieux SA, Abbott Laboratories, QIAGEN, Becton Dickinson & Company, Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc, GE Healthcare, BioGenex, and Cell Signaling Technology, Inc.